STAT3 and hepatocellular carcinoma: Metformin by itself can promote ferroptosis and increase sorafenib sensitivity in HCC by the downregulation of transcription factor 4 (ATF-4), which in turn inhibits the nuclear translocation of phosphorylated STAT3, promoting ferroptosis [120].